The Association of Prescriber Prominence in a Shared-Patient Physician Network with Their Patients Receipt of Risky drug Combinations
A. James O’Malley(Dartmouth College), Xin Ran(Dartmouth College), Ellen Meara(National Bureau of Economic Research), Erika L. Moen(Dartmouth College), Nancy E. Morden(Dartmouth Institute for Health Policy and Clinical Practice)
Cited by 1
Related Papers
Frequency and Cost of Chemotherapy-Related Serious Adverse Effects in a Population Sample of Women With Breast Cancer
|JNCI Journal of the National Cancer Institute|2006|368
Bisphenol A exposure leads to specific microRNA alterations in placental cells
|Reproductive Toxicology|2010|266
Genome-Wide Variation of Cytosine Modifications Between European and African Populations and the Implications for Complex Traits
|Genetics|2013|143
Prevalence of Children With Medical Complexity and Associations With Health Care Utilization and In-Hospital Mortality
|Archives of Pediatrics and Adolescent Medicine|2022|119